Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 82 for your search:
Drug:  ixabepilone
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA163-046, NCT00080301

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA163-048, NCT00082433

3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Health services research, Tissue collection/Repository, Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: PACS08 - UC-0140/0610, PACS-08/0610, 2006-006494-24, PACS08-Tavlx, BMS-UNICANCER-PACS-08/0610, AMGEN-UNICANCER-PACS-08/0610, FNCLCC-PACS-08/0610, FNCLCC-PACS 08/0610 – TavIx, EU-20804, FNCLCC-Tavlx, BMS-FNCLCC-PACS-08/0610, AMGEN-FNCLCC-PACS-08/0610, NCT00630032

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00476, CTSU 40502, CDR0000617539, NCCTG N063H, CALGB 40502, U10CA031946, U10CA180821, NCT00785291

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: SCRI BRE 145, TITAN, NCT00789581

6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA163-196, 2008-007167-16, NCT00883116

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 11-PIR-11, NCT01492101

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-01064, MSKCC-01064A, NCI-3634, NCT00025194, 3634

9.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03016, NABTT 2111, CDR257118, U01CA062475, JHOC-NABTT-2111, NCT00045708

10.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02523, UPCC-04302, NCI-5787, CDR0000276716, 5787, NCT00057850

11.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000393439, AECM-03099, AECM-CA163402, AECM-NMC-03-10-277C, NCT00096317

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00140, 0504007857, CDR0000441122, 7229, N01CM62204, P30CA013330, AECM-0504007857, NCI-7229, NCT00182767

13.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00155, 055513, CDR0000481121, N01CM62202, UCSF-055513, NCI-7347, 7347, NCT00331344

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: SCRI BRE 138, NCT00825734

15.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: ALSSMBC0804, NCT00924352

16.

Phase: Phase II, Phase I
Type: Treatment
Status: Unknown
Age: 18 and over
Sponsor: NCI
Protocol IDs: SCCC-09809, SCCC-09809, NCT01079793

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: SWOG-S0111, S0111, NCT00016393

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Adult
Sponsor: NCI
Protocol IDs: SWOG-S0107, S0107, NCT00016965

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: CDR0000068644, BMS-MSKCC-01011, MSKCC-01011, NCI-G01-1949, NCT00017043

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-01015, NCI-G01-1950, NCT00017056

21.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-01031, BMS-CA163-009, CPMC-IRB-13916, NCI-G01-1967, NCT00020904

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02390, E3800, U10CA021115, CDR0000068747, ECOG-E3800, NCT00021099

23.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 11003B, UCCRC-11003B, NCI-3670, 3670, NCT00022477

24.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2012-02413, CDR0000068927, GOG-0126M, U10CA027469, NCT00025155

25.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: CDR0000069190, AECM-3632, MCC-12602, NCI-3632, 3632, NCT00030706
1     
New Search